Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Diabetic Retinopathy Competitive Landscape, Pipeline and Market Analysis 2017 - Research and Markets

Research and Markets
Posted on: 24 Aug 17

The "Diabetic Retinopathy - Competitive Landscape, Pipeline and Market Analysis, 2017" report has been added to Research and Markets' offering.

Diabetic Retinopathy - Competitive Landscape, Pipeline and Market Analysis, 2017 provides an overview of the epidemiology trends of Diabetic Retinopathy in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes the historical and forecasted epidemiology data for Diabetic Retinopathy prevalent or incident cases segmented by age, sex and subpopulations.

The report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Diabetic Retinopathy.

Further, therapeutic assessment of pipeline products by mechanism of action (MoA), route of administration (RoA), molecule type, along with latest updates are covered in this report. A comprehensive review of the market trends, drivers, barriers, key company profiles including its business and product developments are also detailed here.

Key Coverage and Benefits:

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Diabetic Retinopathy market
  • Identifying prevalent patient populations as well as risk factors in the global Diabetic retinopathy market will help to improve product design, pricing, and launch plans
  • To understand the current pipeline scenario of different companies so as to make the research activity more robust and competitive
  • To understand the future market competition in the global Diabetic Retinopathy market and Insightful review of the key market drivers and barriers
  • The report also covers the detailed global historical and forecasted Diabetic Retinopathy market covering United States, European Union 5 (EU5 - Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023

Key Topics Covered:

  1. Diabetic Retinopathy (DR) Market Overview at a Glance
  2. Global Market Size of DR in 2016
  3. Global Market Size of DR in 2023
  4. Diabetic Retinopathy: Overview
  5. Stages
  6. Symptoms
  7. Types
  8. Pathophysiology
  9. Etiology
  10. Risk Factors
  11. Disease Burden
  12. Unmet Needs
  13. Epidemiology of Diabetic Retinopathy in 7MM (2013-2023)
  14. Competitive Landscape

Marketed Drugs

  • EYLEA
  • Emixustat HCl: Acucela Inc.

For more information about this report visit https://www.researchandmarkets.com/research/fddb8z/diabetic

View source version on businesswire.com: http://www.businesswire.com/news/home/20170824006033/en/

Business Wire
www.businesswire.com

Last updated on: 24/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.